Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When to treat patients with chronic hepatitis C.

Literature DB >> 15245691

When to treat patients with chronic hepatitis C.

Jenny Heathcote¹, Alnoor Ramji.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2004 PMID： 15245691 DOI： 10.1007/s11894-004-0074-6

Source DB: PubMed Journal: Curr Gastroenterol Rep ISSN： 1522-8037

Keyword Cloud
References

× No keyword cloud information.

26 in total

1. Effect of interferon alfa-2b and ribavirin treatment on hepatitis C-associated cryoglobulinemia and rheumatoid factor: comment on the article by Vassilopoulos and Calabrese.

Authors: Swati Medhekar; Angella Nutt; J P Raufman; Hugo E Jasin
Journal: Arthritis Rheum Date: 2003-02

2. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.

Authors: V Soriano; J García-Samaniego; R Bravo; J González; A Castro; J Castilla; P Martínez-Odriozola; M Colmenero; E Carballo; D Suárez; F J Rodríguez-Piñero; A Moreno; J del Romero; J Pedreira; J González-Lahoz
Journal: Clin Infect Dis Date: 1996-09 Impact factor: 9.079

3. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.

Authors: A Lafeuillade; G Hittinger; S Chadapaud
Journal: Lancet Date: 2001-01-27 Impact factor: 79.321

4. The long-term pathological evolution of chronic hepatitis C.

Authors: M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal: Hepatology Date: 1996-06 Impact factor: 17.425

5. The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.

Authors: S C Gordon; J W Fang; A L Silverman; J G McHutchison; J K Albrecht
Journal: Hepatology Date: 2000-08 Impact factor: 17.425

6. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors: M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal: Lancet Date: 2001-09-22 Impact factor: 79.321

When to treat patients with chronic hepatitis C.

1. Effect of interferon alfa-2b and ribavirin treatment on hepatitis C-associated cryoglobulinemia and rheumatoid factor: comment on the article by Vassilopoulos and Calabrese.

2. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.

3. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.

4. The long-term pathological evolution of chronic hepatitis C.

5. The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.

6. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

7. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

8. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

9. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

10. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.